Toxicology Letters

Article	Citations
S05-03 The development of a human liver-based In Vitro test battery to detect liver steatotic potential of chemicals from various applicability domains	57
P02-46 Cultivation conditions in microfluidic environments: insights from 2D and 3D cell culture models	43
P01-39 Mitochondrial toxicity screening to support the R&D crop protection pipeline	39
P07-09 Spatio-temporal multi-omics analysis of lung tissue and matched biofluids identifies circulatory safety biomarkers for monitoring inhaled drug induced lung injury	38
P02-47 A rat in vitro 3D airway model for translational toxicology	37
S20-04 Generic pharmacokinetic models for mother-to-offspring transfer of environmental chemicals	33
P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity	30
P09-10 The synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial biogenesis of NG108-15 neuroblastoma cells during neuronal differentiation at human-relevant concentrations	30
P08-03 Comprehensive digital documentation and computer-assisted evaluation of the skeleton of Alizarin Red and Alcian Bluestained rat foetuses	29
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies	29
P17-07 Prenatal exposure to acrylamide and metabolic status at 20 years of age: a prospective biomarker-based cohort study from Denmark	27
P21-54 Searching for links in binding patterns among androgen and progesterone receptor ligands	26
The toxicology of inhaled nanomaterials and examples of risk assessment and regulation	25
P19-50 In-chemico reactivity methods based on molecular initiating event of skin sensitization: refinements and possible application to cosmetic formulations	25
P07-18 Acute phase proteins in Göttingen minipigs: comparison between haptoglobin, Pig-MAPP and CRP in the context of a vaccine study	25
P07-05 Miniaturization of haematology sampling in rodents on toxicology studies	25
P08-10 Advancing the use of New Approach Methodologies for assessing teratogenicity using a tiered approach: metabolism consideration to improve the human relevance	22
P13-36 In silico analysis of positive and negative effects of isothiocyanates in breast cancer	22
P14-06 The cytotoxicity of bortezomib in AC16 cardiac cells and possible therapeutic options involving Nrf2	22
P19-03 Integration of transcriptomics data for ED assessments using an Adverse Outcome Pathway Network approach	22
P02-22 Establishment of a microfluidic neurotoxicity screening model using human iPSCs-differentiated motor neurons within the New Approach Methodologies for chemical safety developed for Precision To	22
Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring	21
P20-27 Zinc suphide – considerations and challenges for acute inhalation toxicity testing and classification under REACH	21
LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics	21
P06-04 Advancing bladder cancer detection: unveiling a novel urinary biomarker panel through metabolomics	21

The harmful acute effects of clomipramine in the rat liver: Impairments in mitochondrial bioenergetics	20
S23-02 Assessment and modelling of metabolites: the conazole case study	20
The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice	19
P23-05: Urinary monohydroxyl-polycyclic aromatic hydrocarbons and metals in firefighters with active participation in controlled structure fires	18
LP-17: Evaluation of Genistein as a Mitochondrial Modulator and its Effects on Sperm Motility	18
KL02 | EUROTOX Lecture Award	18
P17-36: Ti-alloy (TiAl6Nb7) metal powder toxicity in human embryonic kidney (HEK-293T) cell line	18
P22-02: The Renal Proximal Tubule TXG-MAPr: Safety Assessment Based On Quantitative Gene Network Analysis	18
OS03-10: Predictive Modeling of Deltamethrin Exposure in Fetal Brain Tissue: Implications for Human Health Risk Assessment	17
P09-46: Preliminary results of the second National Human Biomonitoring program in Slovenia: bisphenols, parabens, PFAS, glyphosate and trace elements in children and adolescents	17
P09-34: Unraveling hormonal dependencies and associated species-specificities of neurodevelopmental key events to improve EDC risk assessment	17
S12A-03: Occupational exposure to copper in dust: Chemical characterization and impact on regulation	17
P19-05: Comparison of in vitro and in vivo study results for classification of plant protection products	17
P22-35: Mapping of DNT NAMs’ signaling pathways in human physiology and disease for regulatory application	16
P10-09: Toxicological aspects of the Horizon EDIAQI project	16
P13-07: High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin	16
P25-13: Polo-like kinase 4 (PLK4) Safety Review – distilling the risks with a rapid augmented intelligence approach	16
P08-18 Predicting non-genotoxic carcinogenic potential of agrochemicals: a mechanistic approach	15
S09-03: NAMs in DART testing of pharmaceuticals under ICHS5(R3)	15
SOC-I-06 Differentially expressed microRNAs in human bronchial epithelial cells after exposure to nanofibrillar, microfibrillar or nanocrystalline cellulose	15
P19-07 Dermal occupational exposure assessment – comparison of selected modeling tools	15
P22-31: Training the next-generation toxicologists	15
P17-26 Assessment of anabolic steroids impact on 5β-reductase by virtual screening and in vitro approaches	15
P08-21 Lack of genotoxicity of Rhamnus Purshiana, Sennae Fructus, and Rhamnus Frangula in a micronucleus assay in vitro (OECD 787)	15
P08-15 Assessing of in vitro genotoxicity testing strategy for T-2 mycotoxin	14
CEC07-03 Towards internal threshold of toxicological concern (iTTC): Implementation of Pharmacokinetics (PK) in the safety assessment	14
P03-03 Autopsy findings and toxicological results in Khat-related fatalities in Jazan, Saudi Arabia	14
P13-07 Addition of physiologically relevant conditions has the potential to effect the toxicology of engineered nanomaterial hazards in an in vitro co-culture of the alveolar region of the lung	14
LP-40: Non-clinical Safety profile of a new i.v. Formulation of Rifabutin (BV100) – an Opportunity for new Treatments	14
P19-08 New values of occupational exposure limits (OELs) of inhalation anesthetics: enflurane, isoflurane, sevoflurane and desflurane in Poland	14
P22-17 Acrylamide exposure estimates in the EuroMix biomonitoring study using a probabilistic approach	13
S-29-02 Assessing the risk of mitochondrially active compounds in medicines development	13
Reviewers	13
P21-17 Risk assessment of chemicals in the Dutch red meat production chain	13
S11-01: A regulatory perspective: hazard identification and potency classification	13
P21-31 Criteria for selecting physiologically-based kinetic models for use in developing new models for data-poor analogues via a read-across approach	13
P06-22 Reproductive and developmental toxicity testing of a complex UVCB: implications of current dose setting advice under REACH for generating meaningful study outcomes	13
P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications	13
P14-04 Compartmental toxicokinetic model for urinary excretion of cleavage products resulting from adducts with globin	13
P16-01 Silver nanoparticles suppressed retinoic acid-induced neuronal differentiation in SH-SY5Y cells	13
P05-06 Protective role of peroxiredoxin V against UVB-induced apoptosis of epidermal keratinocytes	13
P16-05 Influence of the new potential antidepressant SMe1EC2M3 treatment on neuronal outgrowth and arborization	13
P08-08 Toxicogenic effects of leaf extracts from an Andean medicinal plant	12
P04-19 Selecting drug like structures using in silico tools	12
P17-27: Role of oxidative stress in microplastic polymethyl methacrylate (PMMA)-induced hepatotoxicity with HepG2/THP-1 co-culture model	12
S-17-02 Prioritization of contaminants for evaluation in food by WHO/FAO expert committees	12
LP-27: Combination of air- and biomonitoring to control cadmium exposure at the workplace	12
S-01-03 Integrating in vitro distribution kinetics analysis in IVIVE-PBK	12
P22-16: Heated tobacco and e-vapour products induce lower biological activity compared to cigarettes using the ToxProfiler assay	12
S-03-02 Development of T2 MRI biomarker of neurotoxicity as a noninvasive quantitative approach	12

PL04-01 Challenges and opportunities for regulatory toxicology under the chemicals strategy for sustainability	12
LP-46: Counterfeit drugs awareness among a Mexican sample: An underappreciated health risk	12
P09-14 Health Impact of PM2.5 on Pregnant women and Children: Systematic Review	11
P09-33 Oxidative Potential of Traffic-Derived Ultrafine Particles and Their Impact on Olfactory Mucosa Cells in Alzheimer's Disease	11
P07-07 Investigation of the Endocrine Disrupting Effects of Lilial	11
P22-24 Polystyrene nanoplastics induced cognitive impairment through dysregulation of autophagy and synaptic plasticity in rats	11
P12-26 Effect of ketogenic diet on the metabolism of ozanimod in mice	11
Are electric vehicles actually bad for the environment?	11
S02-01 Probabilistic Risk Assessment in Practice	11
P09-11 The disruption of the human astrocytic cell cycle by hexavalent chromium	11
S24-02 Studying and comparing the role of time in in vitroand in vivotoxicity tests	11
S04-03 Sponsor Perspectives on Implementing WOE Approaches	11
P29-11 A delayed activation of p38 MAPK in dendritic cells distinguishes respiratory from skin sensitizers	11
P28-20 Challenges and Best Practices in Conducting Multigenerational Studies: A CRO Perspective	11
OS01-08 Activity-based characterization of New Psychoactive Substances (NPS): a forgotten technology with new forensic applications	11
P33-06 Disruption of the plasma membrane organization and neuroinflammation can be triggered by toxic organophosphorus compounds	11
P14-07 Outcome of the re-assessment of the risks to public health related to the genotoxicity of styrene present in plastic food contact materials	11
S13-02 NAMs to investigate chemical-induced immunotoxicity: the cases of PFAS and BPA analogs	11
CEC04-05 Feasability of quality criteria and tentative assessment tools to align with artificial intelligence	10
P31-33 Classification based risk assessment in the safety evaluation of Extractables & Leachables	10
P23-08 Importance of Buccal Micronucleus Assay in the Biomonitoring of DNA Damage in Paint Workers	10
Individual and mixed effects of PFAS on osteoporosis: Insights from epidemiological and bioinformatic approaches	10
A battery of assays for chasing ricin and its activity	10
P23-11 RVG-modified sEVs selectively delivers BDNF to brain, promotes neurogenesis and mitigates Parkinson-like symptoms	10
S08-02 Current and emerging concepts of cardiotoxicity: applicability inrisk assessment for regulatory purposes	10
S13-04 Skin sensitization potency assessment: Make full use of NAM data to conduct quantitative risk assessment	10
Evidence for adduction of biologic amines with reactive metabolite of 8-epidiosbulbin E acetate in vitro and in vivo	10
S27-03 The microbiome modifies neurobehavior in zebrafish exposed to Aryl Hydrocarbon Receptor (AHR) modulators	10
P23-14 Heavy Metals: Toxicity and Renal Damage	10
P24-11 Waiving of the dog studies in the regulatory process of agrochemicals approval	10
A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure	10
P01-62 Development of an in vitro model of dry nose	9
Advances in understanding the neurotoxicity of lead, cadmium, arsenic, and therapeutic strategies	9
Enhancement of cigarette smoke extract-induced goblet cell metaplasia and hyperplasia exerted through IL-13 receptor α1 expression	9
Skin penetration and decontamination efficacy following in vitro human skin exposure to sulfur mustard	9
P11-01 BPS and BPF by acting as mitochondrial disrupting chemicals cause changes in energy metabolism in human ovarian granulosa cells	9
P02-30 Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay	9
The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms	9
P21-56 Shedding light on the epidermal alterations induced by blue light and heated tobacco products co-exposure: an in vitro study	9
CEC04-02 Comparison of outdoor and indoor air pollution on cardio-pulmonary health	9
P25-07 Do co-formulants influence PPP genotoxicity? – a case study	9
The suitability of a polydimethylsiloxane-based (PDMS) microfluidic two compartment system for the toxicokinetic analysis of organophosphorus compounds	9
Evaluating applicability domain of acute toxicity QSAR models for military and industrial chemical risk assessment	9
circ_0000554 promotes macrophage M2 polarization mediated by glycolytic reprogramming and aggravates COPD injury	9
Comparative effects of e-cigarette and conventional cigarette smoke on in vitro bronchial epithelial cell responses	9
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis	9
Lysosomal membrane permeabilization mediated apoptosis involve in perphenazine-induced hepatotoxicity in vitro and in vivo	9
Comparative toxicity of eleven bisphenol analogs in the nematode Caenorhabditis elegans	9
OS02-03 Using a systems biology approach to construct adverse outcome pathway networks aligned with the FAIR principles	9
P19-32 Advancing the application of New Approach Methodologies (NAMs) in systemic toxicity assessment of cosmetic ingredients: insights from cosmetics Europe long range science strategy (2016–2022) ca	9
CEC01-01 Introduction into the AOP framework: Integrating Theory and Practice in AOP Development	9
S24-02 Biomarkers of neurodevelopmental effect can reduce uncertainty when assessing the risks of thyroid disrupting chemicals	9
P02-18 Using individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage	9
Gentamicin administration leads to synaptic dysfunction in inner hair cells	9
Inhibition of placental 11β-HSD2 expression through cAMP/PKA signaling pathway induces intrauterine growth retardation	9
Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cells	9
Copper exposure at a daily dose twice the recommended in diabetic rats induces oxidative stress, vascular dysfunction and perivascular adipose tissue inflammation in diabetic rats	9
Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats	9
Toxicity prediction using target, interactome, and pathway profiles as descriptors	9
Title Page	9
P26-02 Ensuring pharmaceutical packaging safety: an integrated approach for assessing extractable profiles and toxicological risk	9
P17-03 Toxic and essential metals in breast milk: Preliminary results from Bosnia and Herzegovina	9
P17-21 Effects of early-life BPA analog exposure on natural killer cell function and development	8
LP-22 In vitro Metabolite Profiling of CF3-Etomidate: A New Etomidate Analogs	8
S02-04 Computational Toxicology in Drug Safety	8
P18-15 Determination of tramadol and its metabolite O-desmethyltramadol in blood and vitreous humor samples	8
P01-63 The secretion of interleukin 18 by reconstructed human epidermis is a biomarker for in vitro prediction of skin photosensitization	8
P19-26 Assessment of hepatotoxicity induced by heat-not-burn cigarette extract using various types of hepatocytes	8
PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets	8
S23-04 RapidTox: decision-based workflow environment to advance human health assessment	8
Endocrine disruptors and microplastics: facing complexity with connection	8
P23-11 Assessment of PAH exposure in trainee firefighters using a PAH CALUX bioassay	8
P13-03 Comparative study of mutagenic/antimutagenic and genotoxic/antigenotoxic activities of ethanolic and aqueous extracts prepared from Arbutus unedo fruits	8
P18-62 Mechanistic Insights of BPA Alternatives on PPARγ Binding and Consequences on Adipocyte Differentiation	8
P22-11: Case study of resveratrol as a cosmetic ingredient for systemic toxicity using the new approachmethodologies of next generation risk assessment	8
P03-03 Quantitative in vitro to in vivo extrapolation (QIVIVE) for liver-induced thyroid toxicity risk assessment	8
P09-18 Comprehensive search for genes that vary across three developmental neurotoxicants	8
S12-06 Finding European research funding and writing a competitive research proposal	8
P19-26 Moving towards a framework for in vitro risk assessment and determination of human relevance of rodent liver-mediated thyroid toxicity	8
P24-15 Targeted groundwater monitoring for plant protection products and their metabolites in agricultural regions of Slovenia	7

P20-14 The effect of non-functionalized polystyrene nanoparticles with varying diameters on human albumin (in vitro)	7
P30-59 Interest of the Micronucleus test on Reconstructed Skin and skin organoids for cosmetic products	7
S13-01: How far are we with the implementation of NGRA for cosmetics?	7
Toxicokinetic analysis of the highly toxic nerve agent VX in commercially available multi-organ-chips – Ways to overcome compound absorption	7
P08-15 Evaluation of nanoatrazine bioaccumulation in green microalga Raphidocelis subcapitata: characterization, stability and uptake analysis	7
Editorial Board	7
P31-18 Protective Effects of N-Acetylcysteine and Coenzyme Q10 Against Atorvastatin-Induced Myopathy and Oxidative Damage	7
P23-12 Updating Finnish biomonitoring reference values and health-based guidance values for occupational exposure and risk assessment of selected metals	7
P18-64 Ring trial validation of a cell-based RAR transactivation method	7
P17-13 Optimization of Macrophage Polarization and Phagocytosis Assays for Immunotoxicology Studies	7
P21-12 Investigating the hematotoxic effects of the mixture of lead and polychlorinated-biphenyls by combining in vivo and in silico approach	7
P18-78 What does new nitrosamine data reveal about the CPCA framework?	7
P22-03: Read-Across case study – from hypothesis to regulatory acceptance	7
P04-06: Toxicity of particulate matter from experimental burning of domestic waste	7
P33-05 Preliminary Toxicological Evaluation of Four Candidate Radiosensitizers in Sprague-Dawley Rats	7
S16-03 Microbial pesticides: a regulatory overview	7
S05-03 Shear forces affect cell differentiation and cell sensitivity in organs-on-chip models	7
P03-01 Harnessing the power of AI to drive organ-level toxicity predictions	7
S17-02 OASIS Consortium: Strategies for detecting in vivohepatotoxicity with in vitro‘omic technologies	7
P22-02 Cytotoxic and genotoxic effects induced by aluminium oxide nanoparticles on TM3 Leydig cells	7
S23-01 The ASPIS-initiated Safety Profiling Algorithm (ASPA): setting the stage for Next-Generation Risk Assessment	7
P28-22 Identification of candidate molecular markers for detection of abnormal Mullerian duct morphology in male Japanese quail embryos exposed to estrogenic substances	7
P14-36 Development and optimization of flow cytometry driven analysis of micronucleus in vitro using 3D skin tissues	7
P22-46 Effects of plastic nanoparticles, paracetamol, ibuprofen and their mixtures on steroidogenesis in vitro	7
CEC01-03 The current biological understanding of the respiratory tract, the in vitro models available as well as their use	7
P25-05: Media representation of Glyphosate in Slovenian Printed Media over 10 year period	6
P01-02: An updated adverse outcome pathway network on chemical-induced liver steatosis	6
P03-22: Sensitivity of primary human hepatocytes and HepG2 cells for genotoxicity testing of N-nitrosamines in the in vitro alkaline comet assay	6
P01-04: Development of an Adverse Outcome Pathway (AOP) to assess the neurotoxicity of the exposure to benzo(a)pyrene	6
P04-16 In silico applications for the prediction and hazard assessment of transformation products originated from water disinfection treatment processes	6
P16-17 The senescence-associated secretory phenotype (SASP) from colorectal cancer cells induce neurotoxicity: novel mechanism involvement of CD38-NAD+ pathways	6
LP-20 Halogen-free flame retardant is friendlier to the aquatic environment than PBDEs	6
S-26-01 Methylmercury-induced modification of selenocysteine in selenoprotein P – Implication to its physiological function	6
P17-09: Polystyrene microplastics of varying sizes and shapes induce distinct redox and mitochondrial stress responses in a Caco-2 monolayer	6
KL06 | Keynote Lecture	6
CEC01-01: A hands-on introduction to applied artificial intelligence in toxicology	6
P10-25: Cytotoxic and genotoxic effects of particulate matter emitted in beauty salons	6
Editorial Board	6
P26-11: Acute and subacute toxicity profiles in Sprague-Dawley (SD) rats treated with Piperis Longi Fructus (PLF) Powder	6
P10-03: Cadmium levels are related to clonal hematopoiesis and mortality	6
P08-12 The surfactant co-formulant POEA in the glyphosate-based herbicide RangerPro but not glyphosate alone causes necrosis and ER stress in mammalian cell lines	6
S-31-01 Setting the scene: human health impacts of micro- and nanoplastics (MNPs)	6
P12-08 Biological evaluation of pharmaceuticals inhibiting 11β-hydroxylase identified by virtual screening	6
P12-59 Assessing the placental transfer of dexamethasone via ex vivo human placenta perfusions: a step-up towards model informeddrug dosing in pregnancy	6
P17-12 Molecular network pathway analysis of arsenic and cisplatin in cancer	6
LP-04: Adverse Outcome Pathways of Toxicity-Induced Dry Eye: implication of ferroptosis and pyroptosis in corneal neuroepithelial entity	6
P21-16 Cytotoxicity: regulatory definitions versus scientific knowledge	6
P22-08: New strategies for the safety assessment of proteins in food/feed derived from biotechnology – the way forward	6
CEC06-03: Documenting pesticide exposures from field studies: what is known and why we should know more	6
P11-02: Online methods and tools for assessing chemical exposure in humans: a systematic scoping review for the ONTOX project	6
P23-03: Applying the Multiple Path Particle Dosimetry model for assessing Occupational Exposure to Active Pharmaceutical Ingredients	6
P22-27 Exposure assessment of total DON in urine of Portuguese adult population under the HBM4EU aligned studies	6
P03-04 Validation of an analytical method to identify and quantify selected amphetamine-related drugs (ARDs) in whole blood (WB) using UPLC-qTOF-MS after extraction by MMSPE	6
P22-11 Current challenges in water quality require advanced risk assessment	6
LP-37 Biokinetics of fluorophore-conjugated microplastics in marine mussels	6
P11-26 Exosomes derived from primed mesenchymal stem cells improve cell viability on an APAP-induced hepatic injury in vitro model	6
P17-30: Amorphous silica nanomaterials effects on human dendritic cells promote the T-cell response to the pneumallergen Bet v 1a	6
P11-05 Toxic microelements levels in the blood clot of wild boar (Sus scrofa) for monitoring the contamination and biomarkers changes	6
P06-40: Integrating physiologically-based pharmacokinetic modelling and 'omics data to derive a health-based guidance value for perfluorooctanoic acid	6
P22-05 Identification and hazard assessment of oligoesters, nonintentionally added substances present in food contact coating extracts	6
P16-21: Applications of an isogenic human iPSC-derived blood-brain barrier (BBB) model	6
S21-03 CBD: a reprotoxicant proposed to be identified under CLP	5
P22-35 New methodologies for the hazard assessment of advanced nanomaterials: integration of mechanistic approaches in designed case studies	5
P24-07 Proposal for revision of default dermal absorption values in regulatory toxicology	5
P28-13 Evaluating embryo- and developmental toxicity of pyrethroids and its mixtures in human induced pluripotent stem cell-derived 3D cardiomyocytes	5
P27-10 Application of a quantitative approach to identify Poorly Soluble Particles	5
P21-28 Health risk contamination of Mercury in blood and meat after using autogenous vaccine against Streptococcus agalactiae in Nile Tilapia (Oreochromis Niloticus)	5
P21-34 SARS-CoV-2 omicron infection aggravates lung fibrosis through IL6/ CSF/ RANTES activation and dysfunction of lipid metabolism in mice with PHMG-induced lung injury	5
P23-26 When Smoke Meets Dust: A Toxicological Study of Serum Heavy Metal Levels and Oxidative Stress Markers in Silicosis Patients	5
An integrated in vitro and in silico testing strategy applied to PFAS inhibition of antibody production to define a tolerable daily intake	5
P12-32 An all-human cell based tri-culture system distinguished through morphology, longevity, and functionality	5
P02-14 In vitro 2D and 3D kidney models to study the nephrotoxic response of uranium exposure	5
P10-18 Bayesian benchmark dose modelling of hypothalamic–pituitary–ovarian axis endpoints to assess DEHP exposure effects in female mice	5
P18-89 Bridging Physiological Accuracy and Worldwide Reproducibility: The EpiVaginal™ Model Integrated with Simulated Vaginal Fluid (SVF)	5
P31-05 Monitoring ototoxicity in drug development: robust in vitro & ex vivo models	5
P14-23 Toxic metal levels in cancer patients. Is the cell barrier leaking?	5
P22-34 Synthesis and potential application in melanoma therapy of sodium carboxymethyl cellulose-coated iron oxide nanoparticles loaded with dacarbazine	5
P09-12 Thyroid hormones concentrations in cerebellum, cortex and whole-brain rat samples at certain life stages	5
P05-13 Refining the high potency category rules to enhance the accuracy of exposure-based waiving arguments within a Next Generation Risk Assessment for skin sensitisation	5
P14-01 Initial cytogenotoxic screening of N-tosylindole, a new larvicide against Aedis aegypti, the transmitter of Dengue, Chicungunya and Zika	5
P14-04 The impact of short telomere length on cardiac disease	5
Spilled liquid mercury: Case studies, proposition of safety procedures with assessment of commercial cleanup kit and recommendations	5
P10-12 Investigation of the effects of endocrine disruptors on T cells differentiation	5
LP-23 Molecular glue degrader reproductive toxicity: what did we learn?	5
P26-08 Risk assessment of elemental release from metal kitchenware and hip flasks	5
P29-16 Interspecies Comparison of Inhalation Toxicity of PA-6 Particles: Insights from Transcriptomics in In vivo Rat Studies and In vitro Human Alveolar Models	5
P28-37 Juvenile hormone analog, fenoxycarb induced apoptotic effects in the developing ovary of Daphnia magna	5
P30-64 Exploring AOP-based linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes	5
P18-105 Evaluation of Inhalation and Gastrointestinal Toxicity of Novel Benzoazepine Derivatives with Potential Therapeutic Effects for the Treatment of COVID-19 and Post-COVID Syndrome	5
P14-01 Age-related effects of AT1 receptor antagonist losartan on cognitive decline in spontaneously hypertensive rats	5
P01-58 Comparative mitochondrial changes caused by ionizing radiation in healthy and cancerous lung cells	5
LP-37 Ciprofloxacin alters neuronal epigenetic patterns in vitro and in vivo at therapeutically relevant exposures	5
P05-31 PBK modelling concepts for a user friendly generic bovine kinetic modelling platform to predict transfer of compounds from feed, veterinary medicines and supplements to food	5
miR-520f-3p blocks MNNG-induced gastric precancerous lesions via the KLF7/NFκB pathway	5
P02-40 Novel in vitro protocol for evaluation of safety of intraoral medical devices	5